Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis.

Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. · 2023

Read Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. by Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9971315.txt.

Introduction

Chowdhury and co-authors estimate global and regional prevalence of multimorbidity in adults. Multimorbidity means living with several long-term conditions at once. High rates signal higher death risk and heavier health care use. The review supports a global goal to cut early death from non-communicable diseases.

The team searched PubMed, ScienceDirect, Embase, and Google Scholar. They kept community surveys published from 2000 to 2021. A random-effects model pooled prevalence across studies. The final set held 126 studies with nearly 15.4 million people. Subgroup checks varied by continent, age, sex, and definition used. The authors aimed to show how common multimorbidity is across WHO regions. Their pooled picture guides health system planning.

Catalog record

CREATORChowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE76 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9971315

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis By Saifur Rahman Chowdhury, Dipak Chandra Das, Tachlima Chowdhury Sunna, Joseph Beyene, Ahmed Hossain Published in: eClinicalMedicine DOI: 10.1016/j.eclinm.2023.101860 ABSTRACT Summary Background Knowing the prevalence of multimorbidity among adults across continents is a crucial piece of information for achieving Sustainable Development Goal 3.4, which calls for reducing premature death due to non-communicable diseases. A high prevalence of multimorbidity indicates high mortality and increased healthcare utilization. We aimed to understand the prevalence of multimorbidity across WHO geographic regions among adults. Methods We performed a systematic review and meta-analysis of surveys designed to estimate the prevalence of multimorbidity among adults in community settings. We searched PubMed, ScienceDirect, Embase and Google Scholar databases for studies published between January 1, 2000, and December 31, 2021. The random-effects model estimated the pooled proportion of multimorbidity in adults. Heterogeneity was quantified using I2 statistics. We performed subgroup analyses and sensitivity analyses based on continents, age, gender, multimorbidity definition, study periods and sample size. The study protocol was registered with PROSPERO (CRD42020150945). Findings We analyzed data from 126 peer-reviewed studies that included nearly 15.4 million people (32.1% were male) with a weighted mean age of 56.94 years (standard deviation of 10.84 years) from 54 countries around the world. The overall global prevalence of multimorbidity was 37.2% (95% CI = 34.9–39.4%). South America (45.7%, 95% CI = 39.0–52.5) had the highest prevalence of multimorbidity, followed by North America (43.1%, 95% CI = 32.3–53.8%), Europe (39.2%, 95% CI = 33.2–45.2%), and Asia (35%, 95% CI = 31.4–38.5%). The subgroup study highlights that multimorbidity is more prevalent in females (39.4%, 95% CI = 36.4–42.4%) than males (32.8%, 95% CI = 30.0–35.6%). More than half of the adult population worldwide above 60 years of age had multimorbid conditions (51.0%, 95% CI = 44.1–58.0%). Multimorbidity has become increasingly prevalent in the last two decades, while the prevalence appears to have stayed stable in the recent decade among adults globally. Interpretation The multimorbidity patterns by geographic regions, time, age, and gender suggest noticeable demographic and regional differences in the burden of multimorbidity. According to insights about prevalence among adults, priority is required for effective and integrative interventions for older adults from South America, Europe, and North America. A high prevalence of multimorbidity among adults from South America suggests immediate interventions are needed to reduce the burden of morbidity. Furthermore, the high prevalence trend in the last two decades indicates that the global burden of multimorbidity continues at the same pace. The low prevalence in Africa suggests that there may be many undiagnosed chronic illness patients in Africa. Funding None. Keywords: Multimorbidity, Systematic review, Meta-analysis, Global prevalence, Chronic disease Research in contextEvidence before this studyWe searched PubMed, ScienceDirect, and Google Scholar for peer-reviewed papers and research reports on the prevalence of multimorbidity, using the search words 'prevalence' and 'multimorbidity' and similar terms published between January 1, 2000 and December 31, 2021. One meta-analysis combined 68 studies from 1992 to 2017 and showed that the global pooled prevalence of multimorbidity in community settings was 33.1%. In 2021, another meta-study focused on articles that investigated people in community settings from Latin America and the Caribbean.Added value of this studyThis research used studies until 2021 to analyze multimorbidity prevalence in community settings worldwide. South America has the highest prevalence of multimorbidity when comparing prevalence estimates across geographic regions. The prevalence difference was obtained across age groups, gender, country and income level, and study periods. For the first time in a subgroup study, we stratified the number of conditions to estimate the prevalence of multimorbidity. Studies that included mental health in the definition of multimorbidity resulted in a high pooled prevalence. Our research also uses statistical techniques to estimate the pooled prevalence of multimorbidity in adults while capturing heterogeneity in the estimates. This study summarizes the available evidence and encourages policymakers to use more standardized methods to reduce the burden of multimorbidity, which is a critical step toward meeting the sustainable development goal (SDG) goal of reducing premature mortality from non-communicable diseases by one-third through prevention and treatment by 2030.Implications of all the available evidenceOur findings show that the landscape of multimorbidity prevalence has increased in the last two decades though it has remained relatively unchanged since 2010, implying a slow reduction in the burden of multimorbidity. About half of the South American adult population had multimorbidity, and thus these countries should take it as a priority agenda to develop more sustainable and integrated models of care. Research like this is crucial as the world tries to balance lowering the expense of multimorbidity on society and improving healthcare outcomes. INTRODUCTION Multimorbidity has emerged as a significant public health issue in the world. It is typically defined as the presence of two or more chronic conditions at the same time in one individual.1 Multimorbidity has increased in various population groups due to population aging, lifestyle changes, improved socioeconomic conditions, and improved diagnostic capabilities by health services.2, 3, 4 Due to a lack of data from low-income countries and the use of different definitions of multimorbidity, a recent systematic review highlighted the need to estimate the prevalence of multimorbidity and patterns of multimorbidity.5 The high prevalence of multimorbidity has several negative consequences, including a high mortality rate, increased healthcare utilization, and increased healthcare expenses, influencing overall functioning and quality of life.6, 7, 8, 9, 10 According to a recent review and meta-analysis, those with at least two morbidities have a 1.73 times higher risk of death than people without multimorbidity.8 Moreover, healthcare demands and costs of multimorbidity continue to rise as populations age.11 Although few systematic reviews and meta-analyses on multimorbidity in community settings have been published in recent years, these included fewer studies or are restricted to a specific geographic region.12, 13, 14, 15 According to a systematic review and meta-analysis of studies with data collected between 1992 and 2017, the global pooled prevalence of multimorbidity in community settings was 33.1% (95% confidence interval: 30.0–36.3%).12 This prior study, however, did not look at how multimorbidity patterns changed over time or gave insight into multimorbidity definitions based on the number of conditions. In recent years, many studies have been conducted to identify the clinical patterns of chronic conditions.14,16, 17, 18, 19 Two systematic reviews on multimorbidity identified depression, hypertension, and diabetes as the most prevalent co-occurring chronic diseases.5,20 Another study of multimorbidity identified cardiovascular and metabolic diseases as the most common diseases, followed by mental health disorders and musculoskeletal conditions.21 In a multi-national cross-sectional study of non-institutionalized adults aged 50 and over in Finland, Poland, Spain, China, Ghana, India, Mexico, Russia, and South Africa, hypertension, cataract, and arthritis were the most prevalent comorbid conditions.22 A study conducted in Germany among health-insured individuals aged 65 and older identified three broad multimorbidity patterns–cardiovascular/metabolic disorders, anxiety/depression disorders, and pain/neuropsychiatric disorders.23 It indicates that mental health disorders were prevalent in the studies, so we examined the prevalence of multimorbidity with and without mental health disorders. These findings provide an explanation for the clinical patterns as well as the burden of multimorbidity that was observed among the studied people. An accurate and up-to-date prevalence estimation is critical

Read the complete text